19.05.2013 Views

AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore

AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore

AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

28<br />

impaired microvascular perfusion <strong>in</strong> sepsis requires<br />

activated coagulation and p-select<strong>in</strong>-mediated<br />

platelet adhesion <strong>in</strong> capillaries<br />

F. Li<br />

C.G. Ellis<br />

M.D. Sharpe<br />

P.L. Gross<br />

J.X. Wilson<br />

K. Tyml<br />

Critical Illness Research,<br />

Victoria Research<br />

Laboratories, Lawson Health<br />

Research Institute, London,<br />

ON, Canada<br />

PURPOSE: Impaired microvascular perfusion <strong>in</strong> sepsis is not treated effectively<br />

because its mechanism is unknown. S<strong>in</strong>ce <strong>in</strong>flammatory and coagulation<br />

pathways cross-activate, we tested if stoppage of blood flow<br />

<strong>in</strong> septic capillaries is due to oxidant-dependent adhesion of platelets <strong>in</strong><br />

these microvessels.<br />

METhOdS: Sepsis was <strong>in</strong>duced <strong>in</strong> wild type, eNOS(-/-), iNOS(-/-), and gp91phox(-/-)<br />

mice (n = 14-199) by <strong>in</strong>jection of feces <strong>in</strong>to the peritoneum.<br />

Platelet adhesion, fibr<strong>in</strong> deposition, and blood flow stoppage <strong>in</strong> capillaries<br />

of h<strong>in</strong>dlimb skeletal muscle were assessed by <strong>in</strong>travital microscopy.<br />

Prophylactic treatments at the onset of sepsis were <strong>in</strong>travenous <strong>in</strong>jection<br />

of platelet-deplet<strong>in</strong>g antibody, P-select<strong>in</strong> block<strong>in</strong>g antibody, ascorbate,<br />

or antithromb<strong>in</strong>. Therapeutic treatments (delayed until 6 h) were <strong>in</strong>jection<br />

of ascorbate or the glycoprote<strong>in</strong> IIb/IIIa <strong>in</strong>hibitor eptifibatide, or local<br />

superfusion of the muscle with NOS cofactor tetrahydrobiopter<strong>in</strong> or NO<br />

donor S-nitroso-N-acetylpenicillam<strong>in</strong>e (SNAP).<br />

RESULTS: Sepsis at 6-7 h markedly <strong>in</strong>creased the number of stopped-flow<br />

capillaries and the occurrence of platelet adhesion and fibr<strong>in</strong> deposition<br />

<strong>in</strong> these capillaries. Platelet depletion, iNOS and gp91phox deficiencies,<br />

P-select<strong>in</strong> blockade, antithromb<strong>in</strong>, or prophylactic ascorbate prevented,<br />

whereas delayed ascorbate, eptifibatide, tetrahydrobiopter<strong>in</strong>, or SNAP<br />

reversed, septic platelet adhesion and/or flow stoppage. The reversals by<br />

ascorbate and tetrahydrobiopter<strong>in</strong> were absent <strong>in</strong> eNOS(-/-) mice. Platelet<br />

adhesion predicted 90% of capillary flow stoppage.<br />

COnCLUSIOn: Impaired perfusion and/or platelet adhesion <strong>in</strong> septic capillaries<br />

requires NADPH oxidase, iNOS, P-select<strong>in</strong>, and activated coagulation,<br />

and is <strong>in</strong>hibited by <strong>in</strong>travenous adm<strong>in</strong>istration of ascorbate and by<br />

local superfusion of tetrahydrobiopter<strong>in</strong> and NO. Reversal of flow stoppage<br />

by ascorbate and tetrahydrobiopter<strong>in</strong> may depend on local eNOSderived<br />

NO which dislodges platelets from the capillary wall.<br />

Intensive Care Med 2010;36(11):1928-34

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!